Finding 395648 (2023-002)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2023
Accepted
2024-05-01

AI Summary

  • Core Issue: The Association's IT controls failed to prevent double reimbursement of claims under the 1332 Waiver program.
  • Impacted Requirements: Costs must comply with federal funding principles and grant conditions, specifically 45 CFR Part 75, Subpart E.
  • Recommended Follow-Up: Management should enhance IT systems to detect and prevent duplicate claims, ensuring compliance and safeguarding federal funds.

Finding Text

U.S. Department of Health and Human Services Federal Financial Assistance Listing 93.423 1332 State Innovation Waivers Activities Allowed or Unallowed and Allowable Costs/Cost Principles Significant Deficiency in Internal Control in Federal Compliance Criteria: Costs charged to the federal funds under the 1332 Waiver program must comply with the cost principles at 45 CFR Part 75, Subpart E, and any other requirements or restrictions on the use of federal funding outlined in the grant Standard Terms and Conditions. Condition: The Association’s existing controls over their IT environment for reviewing and reimbursing carriers for claims was not able to detect and prevent a claim from being reimbursed twice. Cause: The Association began working with a new carrier, Aetna, and did not modify their IT environment for this specific carrier to ensure that claims being reimbursed were not able to be duplicated. Effect: A claim was able to be reimbursed to a carrier twice using federal monies. Questioned Costs: $74,799.52 Context/Sampling: A nonstatistical sample of 60 claims out of 89,552 claims were selected for testing. Repeat Finding from Prior Year(s): No Recommendation: Management should implement parameters in their IT environment that allow them the ability to detect and prevent a claim being duplicated and paid out twice. Views of Responsible Officials: Management of the Association agrees with the finding.

Corrective Action Plan

Finding 2023‐002 Federal Agency Name: U.S. Department of Health and Human Services Pass‐Through Entity: Federal Financial Assistance Listing 93.423 Assistance Listing Number: 1332 State Innovation Waivers Program Name: Maine Guaranteed Access Reinsurance Association (MGARA) Finding Summary: The Association’s existing controls over their IT environment for reviewing and reimbursing carriers for claims was not able to detect and prevent a claim from being reimbursed twice.Corrective Action Plan: The duplicate payment to Aetna was requested back to the program and will be received in April 2024. Going forward, the administrator will run reports at the beginning of each calendar year to ensure that all insurance carrier exception reports are generated. This will ensure that whenever claims are processed that all duplicate claims will be identified and denied. Responsible Individual(s): Diane Kopecky, administrator Anticipated Completion Date: April 2024

Categories

Allowable Costs / Cost Principles Significant Deficiency

Other Findings in this Audit

  • 972090 2023-002
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.423 State Innovation Waivers $63.48M